The new offer improves upon Pfizer’s earlier proposal for US$86.20 (RM359.97) a share including milestone payments, said the ...

Pfizer has submitted a sweetened bid for Metsera, an obesity drug developer, as its fight against rival Novo Nordisk ...

NEW YORK/LONDON (Reuters) -A bidding war over U.S. biotech Metsera was coming to a head on Thursday, with Danish drugmaker ...

Pfizer Inc. has submitted a sweetened bid for obesity drug startup Metsera Inc. as its fight against rival Novo Nordisk A/S ...

Democratic Senate Minority Leader Chuck Schumer proposed extending expiring health-care subsidies for one year as part of a measure to reopen the government, in a move aimed at breaking the monthlong ...

During a press conference to announce a drug price deal for GLP-1s, President Donald Trump asked for more details about the ...

Amid Novo Nordisk and Pfizer’s whiplash contest for obesity biotech Metsera, Novo’s CEO has, quite literally, told its rival to put its money where its mouth is. | Amid Novo Nordisk and Pfizer’s ...

Eli Lilly and Novo Nordisk have agreed pricing deals for GLP-1RA brands, a pivotal moment in the obesity treatment market.

Eli Lilly and Novo are preparing to announce new drug pricing deals with the White House, including for their blockbuster weight loss drugs. Blackstone Life Sciences will pay Merck $700 million for ...

Futures for the S&P 500 and Nasdaq 100 were little changed after earlier gains of as much as 0.4%. The moves came after a ...

Trump’s Lilly-Novo deal; Metsera takeover bids are raised; FDA releases second round of national priority vouchers. President Donald Trump struck a deal with Eli Lilly and Novo Nordisk to lower the ...

The founders of Metsera have a battle to buy their company. It would be their second time striking deal gold.